High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients

Clinica Chimica Acta

Volumn 415, Issue , 2013, Pages 25-30

  Chen, Chih Jung ^a,b,c   Sung, Wen Wei ^a   Su, Tzu Cheng ^b   Chen, Mu Kuan ^a,b   Wu, Pei Ru ^b   Yeh, Kun Tu ^a,b   Ko, Jiunn Liang ^a,d   Lee, Huei ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Interleukin 10; Oral cancer; Survival

Indexed keywords

INTERLEUKIN 10;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BETEL NUT; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SMOKING HABIT; TAIWAN; TISSUE MICROARRAY; TUMOR CELL;

ADULT; AGED; ALCOHOL DRINKING; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; SEX FACTORS; SMOKING; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS;

PIPER BETEL;

EID: 84866673992     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.09.009     Document Type: Article

References (38)

1. Barnes L., Eveson J.W., Reichart P., Sidransky D. World Health Organization Classification of tumours. Pathology & Genetics Head and Neck Tumours 2005, IARC Press, Lyon.
2. Chung T.T., Pan M.S., Kuo C.L., et al. Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in Taiwan. Carcinogenesis 2011, 32:1063-1068.
3. Ko Y.C., Huang Y.L., Lee C.H., Chen M.J., Lin L.M., Tsai C.C. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995, 24:450-453.
4. Chiang C.T., Chang T.K., Hwang Y.H., et al. A critical exploration of blood and environmental chromium concentration among oral cancer patients in an oral cancer prevalent area of Taiwan. Environ Geochem Health 2011, 33:469-476.
5. Argiris A., Karamouzis M.V., Raben D., Ferris R.L. Head and neck cancer. Lancet 2008, 371:1695-1709.
6. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
7. Asadullah K., Sterry W., Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 2003, 55:241-269.
8. Asadullah K., Sabat R., Wiese A., Docke W.D., Volk H.D., Sterry W. Interleukin-10 in cutaneous disorders: implications for its pathophysiological importance and therapeutic use. Arch Dermatol Res 1999, 291:628-636.
9. Fiorentino D.F., Zlotnik A., Vieira P., et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991, 146:3444-3451.
10. Matsuda M., Salazar F., Petersson M., et al. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 1994, 180:2371-2376.
11. Fortis C., Foppoli M., Gianotti L., et al. Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lett 1996, 104:1-5.
12. Fujieda S., Lee K., Sunaga H., et al. Staining of interleukin-10 predicts clinical outcome in patients with nasopharyngeal carcinoma. Cancer 1999, 85:1439-1445.
13. Hatanaka H., Abe Y., Kamiya T., et al. Clinical implications of interleukin (IL)-10 induced by non-small-cell lung cancer. Ann Oncol 2000, 11:815-819.
14. Heckel M.C., Wolfson A., Slachta C.A., et al. Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70. Cell Immunol 2011, 266:143-153.
15. Cacev T., Radosevic S., Krizanac S., Kapitanovic S. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 2008, 29:1572-1580.
16. Gholamin M., Moaven O., Memar B., et al. Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma. World J Surg 2009, 33:1439-1445.
17. Chan S.L., Mo F.K., Wong C.S., et al. A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma. Cancer 2012, 118:3984-3992.
18. Gaiolla R.D., Domingues M.A., Niero-Melo L., de Oliveira D.E. Serum levels of interleukins 6, 10, and 13 before and after treatment of classic Hodgkin lymphoma. Arch Pathol Lab Med 2011, 135:483-489.
19. De Vita F., Orditura M., Galizia G., et al. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer 1999, 86:1936-1943.
20. Vairaktaris E., Yapijakis C., Serefoglou Z., et al. The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma. Anticancer Res 2008, 28:309-314.
21. Yao J.G., Gao L.B., Liu Y.G., Li J., Pang G.F. Genetic variation in interleukin-10 gene and risk of oral cancer. Clin Chim Acta 2008, 388:84-88.
22. Wang J., Ding Q., Shi Y., et al. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis. Mutagenesis 2011, 27:305-312.
23. Ni P., Xu H., Xue H., Lin B., Lu Y. A meta-analysis of interleukin-10-1082 promoter polymorphism associated with gastric cancer risk. DNA Cell Biol 2012, 31:582-591.
24. Wei Y.G., Liu F., Li B., et al. Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis. World J Gastroenterol 2011, 17:3941-3947.
25. Fujieda S., Sunaga H., Tsuzuki H., Fan G.K., Saito H. IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma. Cancer Lett 1999, 136:1-9.
26. Alhamarneh O., Agada F., Madden L., Stafford N., Greenman J. Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. Head Neck 2011, 33:415-423.
27. Chen C.J., Hsu L.S., Lin S.H., et al. Loss of nuclear expression of Kruppel-like factor 4 is associated with poor prognosis in patients with oral cancer. Hum Pathol 2012, 43:1119-1125.
28. Sorrentino C., Scarinci A., D'Antuono T., et al. Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection. J Pathol 2006, 209:400-410.
29. Viard-Leveugle I., Veyrenc S., French L.E., Brambilla C., Brambilla E. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. J Pathol 2003, 201:268-277.
30. Chandler S.W., Rassekh C.H., Rodman S.M., Ducatman B.S. Immunohistochemical localization of interleukin-10 in human oral and pharyngeal carcinomas. Laryngoscope 2002, 112:808-815.
31. Young M.R., Neville B.W., Chi A.C., Lathers D.M., Gillespie M.B., Day T.A. Autocrine motility-stimulatory pathways of oral premalignant lesion cells. Clin Exp Metastasis 2007, 24:131-139.
32. Szabo G., Mandrekar P., Dolganiuc A., Catalano D., Kodys K. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels. Alcohol Clin Exp Res 2001, 25:1766-1772.
33. Wang C.C., Lin H.L., Liang H.J., Jan T.R. Areca nut extracts enhance the development of CD11b(+) Gr-1(+) cells with the characteristics of myeloid-derived suppressor cells in antigen-stimulated mice. J Oral Pathol Med 2011, 40:769-777.
34. Lim S., Roche N., Oliver B.G., Mattos W., Barnes P.J., Chung K.F. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med 2000, 162:1355-1360.
35. Cesar-Neto J.B., Duarte P.M., de Oliveira M.C., Tambeli C.H., Sallum E.A., Nociti F.H. Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues. J Periodontal Res 2007, 42:184-191.
36. Zeidel A., Beilin B., Yardeni I., Mayburd E., Smirnov G., Bessler H. Immune response in asymptomatic smokers. Acta Anaesthesiol Scand 2002, 46:959-964.
37. Avradopoulos K., Mehta S., Blackinton D., Wanebo H.J. Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck. Ann Surg Oncol 1997, 4:184-190.
38. Chang K.P., Chang Y.T., Liao C.T., et al. Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling. Clin Chim Acta 2011, 412:980-987.